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A B S T R A C T   
Background: Tranquilizer misuse represents a growing international public health problem with heavy social and 
economic consequences. We aimed to identify the psychosocial determinants of this misuse practice, focusing on 
modifiable factors including knowledge and attitudes towards these medications. 
Methods: A prospective cohort study involving 847 adults accompanying children in primary care clinics was 
carried out in Spain. A validated Knowledge, Attitudes and Practices (KAP) questionnaire on tranquilizer use was 
self-administered at baseline, and then participants were followed-up bimonthly. A misuse event was defined as 
unprescribed intake of tranquilizers, storing/sharing leftovers of tranquilizers, and/or not adhering to the pre-
scribed treatment period, timing or dosage. Poisson regression models were applied to estimate adjusted Inci-
dence Rate Ratios (IRRs) of misuse and their 95 % Confidence Intervals (CIs). 
Findings: Individuals’ personal attitudes towards tranquilizers and treating physicians are strongly associated 
with the misuse of these drugs. These attitudes include: individuals’ acceptance of taking tranquilizers to 
improve sleeping [IRR: 5.10 (95 %CI: 2.74–9.48)], to work better [IRR: 2.04 (95 %CI: 1.05–3.99)], or for rec-
reational purposes [IRR: 1.85 (95 %CI: 1.04–3.32)]; willingness to prolong the course of tranquilizer treatment 
without medical consultation [IRR: 2.45 (95 %CI: 1.46–4.13)]; agreeing on storing tranquilizers for possible 
future need [IRR: 5.07 (95 %CI: 2.73–9.40)]; and untrusting the physician’s decision about tranquilizer pre-
scription [IRR: 1.92 (95 %CI: 1.12–3.30)]. The level of knowledge is marginally associated with tranquilizer 
misuse. 
Conclusions: There is a strong association between individuals’ attitudes towards tranquilizers and the misuse 
practices of these drugs. Educational interventional studies could help reduce the incidence of tranquilizer 
misuse.   
1. Introduction 
Tranquilizers are among the most prescribed psychoactive drugs 
(Moore and Mattison, 2017). These medications are considered safe and 
well-tolerated by patients, but they may have important consequences 
on the autonomic nervous system and carry a risk of dependence, 
especially when abused or consumed in high doses (O’Brien, 2005). 
Moreover, although tranquilizers have low toxicity profile, their inges-
tion with other medications such as opioids significantly contributes to 
the risk of overdose (Sun et al., 2017). The concurrent use of tranquil-
izers and opioids is salient internationally, particularly in the United 
States and in some European countries (United Nations Office on Drugs 
and Crime, 2019). 
In 2013, 11 % of the Europeans reported misusing tranquilizers some 
time in their lives and around 6% of the population misused these drugs 
in the last year (Novak et al., 2016). In the past decade, tranquilizer 
misuse has turned into a critical global public health issue (Votaw et al., 
2019). Practices of misuse entail consuming tranquilizers without 
medical prescription and/or poor therapeutic compliance (United Na-
tions Office on Drugs and Crime, 2011). These misuse practices include 
consumption at a higher dose or for a longer period than prescribed, but 
also shortening the course of treatment or reducing the dose as well 
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(Cooper et al., 2007; Julius et al., 2009; Garrido and Boockvar, 2013). 
Recent reports indicated a worldwide worsening of public health in-
dicators concerning tranquilizer misuse (Maree et al., 2016; United 
Nations Office on Drugs and Crime, 2018). The United States witnessed a 
10-fold rise in fatal drug overdose including tranquilizers (National 
Institute on Drug Abuse, 2020), and a 90 % increase in emergency 
department visits for the same cause (Day, 2014). Furthermore, 
non-adherence, with drugs taken at a less quantity than prescribed may 
lead to lower quality of life, poorer management of comorbid physical 
illnesses, increased rates of hospitalization and higher healthcare costs 
(Garrido and Boockvar, 2013; Julius et al., 2009). 
Determinants of tranquilizer misuse remain understudied despite the 
deterioration of related public health indicators (Lembke et al., 2018). 
The available literature is limited to some studies that associated tran-
quilizer misuse with certain demographic characteristics such as sex, 
age, educational level, employment status, and other factors such as 
psychiatric distress, previous prescriptions and quality of life (Becker 
et al., 2007; Opaleye et al., 2013; Tahiri et al., 2017; Votaw et al., 2019). 
Therefore, international efforts should be considerably expanded to 
determine the risk factors of this misuse, and to establish health stra-
tegies that control this problem and enhance awareness about the proper 
prescription and administration of these medicines. 
Knowledge, Attitude and Practice (KAP) questionnaires proved to be 
useful tools in identifying psychosocial properties related to the misuse 
of certain medicines as well as in designing intervention studies and 
related public health approaches. Studies about the association of 
knowledge and attitudes regarding tranquilizers with the misuse prac-
tices of these drugs are scarce. To the best of our knowledge, only two 
related surveys from the past century are available in the literature 
(Manheimer et al., 1973; Clinthorne et al., 1986). 
Accordingly, in the present follow-up study we sought to explore the 
psychosocial determinants of the misuse of tranquilizers in a Spanish 
cohort, with a special focus on the following factors: 1) knowledge about 
tranquilizers, 2) personal attitudes towards tranquilizers and 3) patient- 
healthcare provider relationship. 
2. Methods 
2.1. Setting 
The study was carried out in Galicia, a north-western region of Spain. 
The Spanish National Healthcare System (NHS) provides universal 
coverage to all Spanish citizens and the access to healthcare facilities is 
free of charge. The Spanish NHS also covers medicines that are approved 
and registered by the Agency of Medicines and Health Products. Out-
patients may purchase the prescribed medicines at a reduced cost. The 
dispensing of medicines in general, and of psychoactive drugs in spe-
cific, is strictly controlled and is carried out electronically. 
2.2. Study population and design 
A prospective cohort study that involved adults (≥ 18 years old) from 
the general population was conducted in 2019. The participants con-
sisted of 847 (as per our sample size calculation) adults accompanying a 
next-of-kin to primary care consultations at the University Hospital of 
Santiago de Compostela. The reason for choosing this population was 
the relative ease to have access to it and the high expected responsive-
ness. We contacted all subjects visiting the consultations during the 
recruitment period (May-December 2019). To avoid any misunder-
standing, participants were informed that the questionnaire was about 
personal use of antibiotics, and not about the use in the offspring. No 
further restriction criteria were used in the inclusion of subjects. 
A KAP questionnaire, previously validated in the Spanish general 
population, with Item Content Validity Index (I-CVI) from 0.78 to 1.00), 
Scale Content Validity Index (S-CVI/Ave) of 0.95) and Cronbach’s alpha 
values > 0.6, was applied in this study (Supplementary material, File S1) 
(Mallah et al., 2021). Participants self-administered the questionnaire 
after signing an informed consent form and giving their approval to be 
followed-up every two months for a one-year period. This baseline 
questionnaire needed 10 min to be completed. 
Subsequently, participants were telephoned every two months to 
inquire about their exposure to tranquilizers since the previous contact. 
When a participant doubted if the consumed medicine is classified as 
tranquilizer, we asked about the commercial name of that medicine and 
checked its pharmaceutical classification. If participants reported using 
tranquilizers, they were asked additional questions (Q18 to Q27 of the 
questionnaire) to determine any misuse practice. The follow-up phone 
interview lasted between 1 and 3 min. 
During the follow-up, the participants were reminded about the date 
of the previous contact to help them recall better. Those participants 
who did not answer a follow-up phone call, were telephoned again four 
times subsequently before being excluded from the study. 
2.3. Exposure assessment 
The baseline questionnaire encompassed 16 items (Q1 to Q16) about 
Knowledge, Personal Attitudes towards tranquilizers and patient- 
healthcare provider relationship. These items were answered using a 
0− 10 Likert scale where 0 and 10 represent the lowest and highest de-
grees of agreement, respectively. The knowledge questions entailed the 
consequences of tranquilizer use such as increasing the risk of car ac-
cidents, reducing children’s learning abilities and limiting self-control 
over certain behaviours. Statements of Personal Attitudes towards 
tranquilizers explored the participants’ agreement to use tranquilizers in 
order to sleep or work better, or for recreational purposes. In addition, 
these statements examined the users’ beliefs on how tranquilizers should 
be used. Items about patient-healthcare provider relationship examined 
the level of trust between the patients and their treating physicians as 
well as their satisfaction with the information provided regarding the 
motives of prescription or non-prescription of tranquilizers and the 
clarity of instructions of use given by these physicians. 
2.4. Assessment of misuse of tranquilizers 
A misuse episode was detected when the participants reported using 
tranquilizers without medical prescription or not taking tranquilizers as 
instructed by the physician, including shortening the course of treat-
ment, storing or sharing leftovers of tranquilizers, not taking tranquil-
izers regularly and/or changing the prescribed dosage without medical 
advice. These episodes were detected by asking about the use of tran-
quilizers in the past two months (Q17) and the practices showed with 
respect to the consumed tranquilizers (Q18 to Q28 of the questionnaire). 
2.5. Statistical analysis 
Each participant contributed person-time from the enrolment in the 
study until the date of misuse episode, drop-out, loss to follow-up, or the 
end of the study, whichever occurred first. Each of the 16 Knowledge/ 
Attitude items represented an independent variable that was analysed 
separately. Answers were classified into percentiles of distribution of 
level of agreement or as a dichotomous category depending on the 
question. 
We computed Incidence Rate Ratios (IRRs) and their 95 % Confi-
dence Intervals (CIs) of tranquilizer misuse using Poisson Regression 
models. In the models, the quantile group that represented the highest 
level of knowledge or the perfect attitude was assigned as a reference 
category. Models were directly adjusted for sex and age due to the 
biological relevance of these variables. Other covariates evaluated as 
potential confounders were: employment status, educational level, 
family size, frequency of physician consultation in case of sickness, 
receiving medical prescription over the phone and alcohol consumption. 
They are shown on items Q28 to Q35 of the demographic section of the 
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questionnaire (Supplementary material, File S1). We carried out a uni-
variate regression analysis for each of these covariates as an indepen-
dent variable and tranquilizers misuse as the dependent variable. 
Covariates that showed a p-value smaller than 0.2 were considered as 
potential confounders, were introduced consecutively into the Poisson 
Regression model and only those that modified the IRR of the main 
exposure variable by at least 10 % were retained in the final model 
(Greenland, 1995). In our study, only employment status was deemed a 
confounder and was then included in the multivariate model. Partici-
pants with missing information on any of the covariates were not 
considered in the analysis. 
2.6. Robustness analyses 
2.6.1. Impact of cohort attrition 
In the primary analysis, the IRRs were computed after excluding 
those participants who did not complete any follow-up assessment 
(dropouts). To explore the impact of dropouts and losses to follow up, we 
performed two sensitivity analyses with extreme scenarios. In the first 
analysis, we considered that no subject who dropped out had misused 
tranquilizers. In the second analysis, we assumed that all participants 
with incomplete follow-up had misused tranquilizers. 
To examine the impact of missing data, we performed a multiple 
imputation by chained equations (MICE) procedure. We carried out 20 
imputations using the “mi” suite commands of Stata that follows Rubin’s 
rules for the combination of results across the imputed datasets (Rubin, 
2004). Adjusted IRRs and their 95%CI were then estimated using the 
imputed data. 
2.6.2. Validation sub-study and exposure misclassification 
Due to the absence of any superior instrument that could be 
considered as a “gold standard”, we estimated the specificity and the 
sensitivity of our questionnaire using the results of a reproducibility sub- 
study, carried out in parallel with the main cohort study. This sub-study 
consisted in asking 140 participants to answer our Knowledge and At-
titudes questions on two occasions, with a one-month interval in be-
tween. The objective of this sub-study was to assess reproducibility. 
Reproducibility measures how stable over time the responses were, i.e. 
whether subjects did not answer differently after one month. In the 
analysis phase, each question had to be dichotomized into “good 
knowledge” and “poor knowledge” (or “risky attitude” and risk-free 
attitude” for attitude questions).We considered the answers of the first 
round as the reference, i.e. as the correct (or true) answers, and we 
compared the answers of the second round, assumed to be measured 
with a certain degree of misclassification, to the answers of the first 
round. Sensitivity is the proportion of questions answered as “poor 
knowledge” in the first round, which were answered correctly in the 
second round, while specificity is the proportion of questions answered 
as “good knowledge” in the first round, which were answered correctly 
in the second round. To assess the robustness of our results to exposure 
misclassification, in a secondary analysis, we used the estimated speci-
ficity and sensitivity values of each knowledge and attitude item to 
correct our relative risk estimates. We assumed that there was no loss to 
follow-up. We compared Odds Ratios (ORs) of each item before and after 
correction (Kleinbaum et al., 1982). 
The questionnaire was designed using Remark Office OMR 2014, 
version 9.2.0.20 (Gravic, Inc. 2014. Malvern, PA, USA). All analyses 
were carried out using Stata v12 (StataCorp. 2011. Stata Statistical 
Software: Release 12. College Station, TX: StataCorp LP.) 
2.7. Ethics 
This study was approved by the Ethics Committee of the University 
of Santiago de Compostela (R00002, No. 2019/179), and authorized by 
the Spanish Agency for Medication and Healthcare Products (AEMPS, 
Reference AFG-ANT-2018-01). The study was conducted in compliance 
with the general requirements of the Ethics Committee and with the 
General Data Protection Regulation (Regulation (EU) 2016/679 and 
Organic Law 3/2018). Written informed consent form was obtained 
from the participants and the data were anonymized before analysis. 
3. Results 
Out of 847 recruited participants, 747 (88.19 %) were included in 
the main analysis. Five hundred sixty (74.97 %) were females, and half 
of them were between 36 and 45 years of age (N = 373, 49.93 %). Four 
hundred sixty-two (61.85 %) had university educational level and the 
majority were living in a household of a maximum of four members (N =
609, 81.53 %). Three-quarters of the participants were employed (N =
561, 75.10 %), half of them reported not always visiting the doctor in 
case of sickness (N = 381, 51.00 %) and 299 (40.02 %) individuals 
declared having received a medical prescription over the phone. Four 
hundred twenty-one (56.36 %) participants had never consumed alcohol 
(Table 1). Fifty-eight unique events of misuse of tranquilizers were 
identified in the cohort during the follow-up yielding an overall inci-
dence rate of misuse of 0.17 year− 1. 
3.1. Association of level of Knowledge with tranquilizer misuse 
No association was observed between the low level of knowledge 
regarding the effect of tranquilizers and the misuse of these drugs. Not 
knowing that tranquilizers reduce people’s control over what they do 
[1st tertile IRRQ5: 1.29 (95 %CI: 0.65–2.59)], affect children’s learning 
ability [1st tertile: IRRQ7: 1.17 (95 %CI: 0.58–2.33)], or turn ineffective 
if consumed in excess [IRRQ10: 1.31 (95 %CI: 0.74–2.32)], was not 
associated with increased risk of tranquilizer misuse (Table 2). 
Table 1 
General characteristic of the study population.  
Characteristic Total (N =
747) 
Tranquilizer misusers (N =
58) 
Sex   
Male 187 (25.03 %) 8 (13.79 %) 
Female 560 (74.97 %) 50 (86.21 %) 
Missing 0 0 
Age   
<35 years 131 (17.54 %) 8 (13.79 %) 
36− 45 years 373 (49.93 %) 27 (46.55 %) 
> = 46 years 243 (32.53 %) 23 (39.66 %) 
Missing 0 0 
Educational level   
Until high school 258 (34.54 %) 22 (37.93 %) 
University 462 (61.85 %) 36 (62.07 %) 
Missing 27 (3.61 %) 0 
Family size 
≤4 
609 (81.53 %) 52 (89.66 %) 
>4 111 (14.86 %) 6 (10.34 %) 
Missing 27 (3.61 %) 0 
Consulting a doctor   
Not always 381 (51.00 %) 37 (63.79 %) 
Always 338 (45.25 %) 21 (36.21 %) 
Missing 28 (3.75 %) 0 
Medical consultation over the 
phone 
No 
419 (56.09 %) 29 (50.00 %) 
Yes 299 (40.03 %) 28 (48.28 %) 
Missing 29 (3.88 %) 1 (1.72 %) 
Employment status   
Employed 561 (75.10 %) 39 (67.24 %) 
Unemployed 160 (21.42 %) 19 (32.76) 
Missing 26 (3.48 %) 0 
Alcohol intake   
Never/less than once per month 421 (56.36 %) 35 (60.34 %) 
Others 298 (39.89 %) 23 (39.66 %) 
Missing 28 (3.75 %) 0  
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Table 2 
Incidence Rate Ratio (IRR) of tranquilizers misuse according to quantiles of levels of agreement on knowledge and attitude statements.  





Misuse Crude IRR 
(95%CI) 
Adjusted IRR (95%CI)** 




Q1. I would agree to take tranquilizers in order to sleep better       
1 st tertile 0− 5 9988 18 1 1 1 












Q2. If I feel better after a few days, I sometimes keep taking my 
tranquilizers even after completing the prescribed course of 
treatment       
Totally disagree 0 9776 28 1 1 1 






Q3. I would take tranquilizers in order to enjoy myself with my 
family       
1 st tertile 0 8108 24 1 1 1 












Q4. I would agree to take tranquilizers when I feel down and sad in 
order to work better       
1 st tertile 0− 1 7779 23 1 1 1 












Q5. Tranquilizers reduce people’s control over what they do       












3rd tertile 10 3261 11 1 1 1 
Q6. People taking tranquilizers are at increased risk of traffic 
accidents       












3rd tertile 9− 10 6105 24 1 1 1 
Q7. Psychotropic drugs (such as tranquilizers) may affect children’s 
learning abilities when prescribed to them       












3rd tertile 10 3369 12 1 1 1 
Q8. If I feel side effects during a course of treatment of tranquilizers, I 
should stop taking it as soon as possible       
Disagree 0− 5 6498 25 1 1 1 






Q9. I take the tranquilizers according to the doctor’s instructions       
Totally agree 10 9148 31 1 1 1 






Q10. If tranquilizers are consumed in excess, they won’t work when 
they are really needed       






Agree 6− 10 10452 39 1 1 1 
Q11. I prefer to keep tranquilizers at home in case there is a need for 
them later       
1 st tertile 0 7521 15 1 1 1 












Q12. I trust the doctor’s decision if s/he decides to prescribe or not 
prescribe tranquilizers       
Totally agree 10 7318 22 1 1 1 






(continued on next page) 
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3.2. Association of personal Attitudes with tranquilizer misuse 
Personal attitudes towards tranquilizers are strongly associated with 
their misuse. 
Individuals who would agree to take tranquilizers to sleep (Q1) or 
work (Q4) better are at substantially higher risk of misusing these drugs 
as compared with those who disagree on using tranquilizers for these 
motives [3rd tertile: IRRQ1: 5.10 (95%CI: 2.74–9.48) and IRRQ4: 2.04 
(95%CI: 1.05–3.99)] (Table 2). 
Subjects who did not totally disagree on keeping taking tranquilizers 
even after completing the prescribed course of treatment (Q2) are twice 
more likely to misuse tranquilizers than those who totally disagree on 
extending the use of tranquilizers beyond the prescribed period [IRRQ2: 
2.45 (95%CI: 1.46–4.13)] (Table 2). 
Similarly, individuals who do not completely reject the use of tran-
quilizers for recreational purposes (Q3) are at higher risk of misusing 
these drugs in comparison with subjects who totally disagree on taking 
tranquilizers for this purpose [2nd tertile: IRR: 1.85 (95%CI: 
1.04–3.32)] (Table 2). A similar association, albeit not statistically sig-
nificant, was observed at higher levels of agreement [3rd tertile: IRR: 
1.87 (95%CI: 0.91–3.85)] (Table 2). 
The probability of tranquilizers misuse by individuals who prefer to 
store tranquilizers at home for a potential need in the future (Q11) is five 
times higher than that of subjects who totally disagree on storing tran-
quilizers [IRR: 5.07 (95%CI: 2.73–9.40)] (Table 2). 
3.3. Association of patient’s Attitudes towards their healthcare provider 
with tranquilizer misuse 
Lack of trust and communication between patients and healthcare 
providers with regards to tranquilizer prescription is associated with 
their misuse. 
Adults who do not fully trust the decision of their physician about 
tranquilizer prescription (Q12) are almost twice more likely to misuse 
these drugs when compared with subjects who fully trust their physician 
[IRR: 1.92 (95%CI: 1.12–3.30)] (Table 2). 
Individuals who believe that doctors do not often explain clearly to 
the patient the motives of prescribing or not prescribing tranquilizers 
(Q14) seem to be more likely to misuse these drugs, although the as-
sociation observed is not statistically significant [2nd tertile: IRR: 1.98 
(95%CI: 0.97–4.06)] (Table 2). 
3.4. Robustness analyses 
Assuming that all individuals who were lost to follow up had not 
misused tranquilizers yielded similar results to those of the main anal-
ysis. Conversely, under the assumption that all lost to follow-up were 
misusers, the magnitude of the effect was meaningfully smaller. 
Our multiple imputation analysis (Table 2) confirmed the association 
of Knowledge and Attitudes with the misuse Practices of tranquilizers, 
yet with lower strength. The highest changes were observed in the IRR 
estimates of Q1 [agreeing to take tranquilizers in order to sleep better] 
(from 5.10, 95%CI: 2.74–9.48 to 2.16, 95%CI: 1.46–3.19), Q2 [taking 
tranquilizers even after completing the prescribed course of treatment] 
(from 2.45, 95%CI: 1.46–4.13 to 1.58, 95%CI: 1.11–2.26), and Q11 
[storing tranquilizers for later use] (from 5.07, 95%CI: 2.73–9.40 to 
1.70, 95%CI: 1.13–2.56). 
After correction for non-differential exposure misclassification using 
our sensitivity and specificity estimates, the increase in the Odds Ratios 
was particularly high for Q2 [taking tranquilizers even after completing 
the prescribed course of treatment], Q3 [taking tranquilizers for recre-
ational purposes], Q6 [whether tranquilizers increase the risk of traffic 
accidents], Q13 [trying to obtain tranquilizers at the pharmacy without 
a prescription], Q14 [whether doctors explain the reasons for prescrib-
ing or not prescribing tranquilizers] and Q16 [whether pharmacists 
explain the importance of therapeutic adherence] (data not shown). 
4. Discussion 
Our results show that tranquilizer misuse is substantially associated 
with personal attitudes toward tranquilizers and patient - healthcare- 
provider relationship. Conversely, previous knowledge does not seem to 
be related to misuse. These findings are not easily ascribed to con-
founding, misclassification, or bias from loss to follow-up. 
Table 2 (continued ) 





Misuse Crude IRR 
(95%CI) 
Adjusted IRR (95%CI)** 




Q13. If I believe that I need a tranquilizer and the doctor did not 
prescribe it, I will get it at the pharmacy without a prescription       
Totally disagree 0 10882 38 1 1 1 






Q14. Doctors often explain clearly to the patient the reasons for 
prescribing or not prescribing tranquilizers       












3rd tertile 10 3630 11 1 1 1 
Q15. Doctors often explain clearly to the patient the instructions for 
the use of tranquilizers       






Totally agree 8− 10 6810 30 1 1 1 
Q16. When you buy tranquilizers, the pharmacist tells you about the 
importance of correct therapeutic compliance/ adherence       












3rd tertile 9− 10 3440 17 1 1 1 
IRR: Incidence Rate Ratio; CI: Confidence Interval. 
* Participants level of agreement on the corresponding statement expressed in a 0− 10 Likert scale. 
** IRR adjusted for sex, age and occupational status. 
N. Mallah et al.                                                                                                                                                                                                                                 
Drug and Alcohol Dependence 225 (2021) 108793
6
The prospective study design ensured that usual knowledge and atti-
tudes were assessed before the determination of misuse episodes, and 
thus prevented differential reporting of knowledge and attitudes between 
misusers and non-misusers. 
Furthermore, we adjusted for factors potentially linked to misuse, 
and conducted sensitivity analyses to assess the influence of loss to 
follow-up, but the results did not materially change. 
Patients’ decision of using a certain medicine and their adherence to 
the treatment instructions is highly affected by their awareness of the 
risks associated with the medication (Von Wartburg, 1984). In addition, 
in the case of tranquilizers, individuals’ perception of prescription drugs 
as being socially accepted, safe and easily obtainable encourage their 
use (Quintero et al., 2006; Weyandt et al., 2009). In Spain, tranquilizers 
cannot be obtained without a medical prescription. Nonetheless, misuse 
can still take place as patients may fail to adhere to the treatment 
regimen, store leftovers of tranquilizers or share these drugs with 
someone else. The high obtainability of drugs influences the individual’s 
perception or behaviour towards those drugs and promote their misuse 
(Gillespie et al., 2009; Gras et al., 2020; Wills et al., 1996). A recent 
study reported an increased prevalence of self-medication in Spain 
(Niclos et al., 2018), and previous prescriptions and friends were iden-
tified as the most common sources of self-medication (Bennadi, 2013). 
Almost all participants in our study were in the working age and 
one-third of the misusers of tranquilizers were unemployed when they 
enrolled in the study. Unemployment has a negative impact on the 
psychological state and mental health of the working-age population 
and thus, may increase the consumption of tranquilizers (Batic-Muja-
novic et al., 2017; Navarro-Mateu et al., 2015). 
We reported that individuals who would accept prolonging the use of 
tranquilizers even after improving are at substantial higher risk of 
misusing tranquilizers. Patients who use tranquilizers for a long time can 
experience physical dependence on these drugs. In fact, benzodiaze-
pines, which represent the major class of tranquilizers, are safe if used 
for two to four weeks. Beyond the one-month use, half of patients start to 
develop dependence (De las Cuevas et al., 2003; Lader, 2011). Benzo-
diazepines affect the central nervous system, and their mechanisms of 
action is similar to that of other addiction drugs (Luscher and Ungless, 
2006; Saal et al., 2003; Tan et al., 2010). 
The present study suffers from some limitations. Studies relying on 
observations of individuals are prone to a bias known as “Hawthorne 
effect”, i.e. individuals participating in research studies tend to enhance 
their behavior due to the feeling of being invigilated (McCambridge 
et al., 2014). Another related bias is “social desirability bias” (Tour-
angeau and Yan, 2007), where participants fail to report their misuse 
practices towards tranquilizers and tend to give socially accepted an-
swers. In our study, we measured the exposure (Knowledge and Atti-
tude) at baseline only, and thus it is possible that some participants 
might have changed their exposure category during the follow-up and 
improved their use of tranquilizers. 
Previous studies showed that individuals with low level of knowl-
edge are less likely to respond to research studies (Purdie et al., 2002; 
Tolonen et al., 2005), and may then abandon follow-up more frequently, 
therefore introducing a selection bias. Nonetheless, this was unlikely to 
take place in our study as individuals who abandoned the study after 
baseline assessment and those who completed the follow-up question-
naires had similar levels of knowledge and attitudes. Furthermore, loss 
to follow-up in our study, although limited to 11 % of the population, 
may have reduced the number of events of misuse of tranquilizers during 
the follow up, decreasing therefore the statistical power of the observed 
associations. 
In summary, we found substantial evidence of an association be-
tween inappropriate attitudes and tranquilizer misuse. The association 
persisted after control for several potential determinants. Future studies 
in different settings and cultures are needed to confirm further these 
associations. These findings might help design intervention studies to 
enhance the rationale use of tranquilizers. 
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